Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GLOBUS MEDICAL INC (GMED)
|
Add to portfolio |
|
|
|
| Price: |
$73.94
| | Metrics |
| OS: |
100.5
|
M
| |
|
|
| Market cap: |
$7.43
|
B
| |
|
|
|
Net cash:
|
$1
|
B
| |
$10.00
|
per share
|
|
EV:
|
$6.42
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$310
|
M
| |
20.8
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 1,022.8 | 958.1 | 789.0 | 785.4 | 713.0 | 636.0 | 564.0 | 544.8 |
| Revenue growth | 6.8% | 21.4% | 0.5% | 10.2% | 12.1% | 12.8% | 3.5% | 14.8% |
| Cost of goods sold | 263.7 | 239.2 | 217.5 | 180.0 | 159.4 | 150.5 | 134.7 | 132.3 |
| Gross profit | 759.1 | 718.9 | 571.6 | 605.4 | 553.6 | 485.5 | 429.3 | 412.4 |
| Gross margin | 74.2% | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.7% |
| Selling, general and administrative | 531.2 | 546.9 | 460.1 | 433.4 | 384.2 | 323.7 | 222.2 | 210.2 |
| Research and development | | | | | | | 44.5 | 36.3 |
| EBITA | 259.0 | 232.7 | 166.4 | 203.3 | 192.6 | 178.9 | 159.4 | 177.1 |
| EBITA margin | 25.3% | 24.3% | 21.1% | 25.9% | 27.0% | 28.1% | 28.3% | 32.5% |
| Amortization of intangibles | 17.7 | 18.5 | 16.8 | 13.8 | 9.6 | 7.9 | 3.5 | 1.6 |
| EBIT | 241.3 | 214.1 | 149.5 | 189.5 | 183.0 | 171.0 | 156.0 | 175.6 |
| EBIT margin | 23.6% | 22.4% | 19.0% | 24.1% | 25.7% | 26.9% | 27.7% | 32.2% |
| Pre-tax income | 243.0 | 180.4 | 125.9 | 189.9 | 188.6 | 169.9 | 157.3 | 172.8 |
| Income taxes | 52.9 | 31.2 | 23.6 | 34.7 | 32.1 | 62.6 | 52.9 | 60.0 |
| Tax rate | 21.7% | 17.3% | 18.8% | 18.3% | 17.0% | 36.8% | 33.7% | 34.7% |
| Net income | 190.2 | 149.2 | 102.3 | 155.2 | 156.5 | 107.3 | 104.3 | 112.8 |
| Net margin | 18.6% | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% |
| |
| Diluted EPS | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 |
| Shares outstanding (diluted) | 102.6 | 103.6 | 101.0 | 102.0 | 101.3 | 97.9 | 96.4 | 96.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|